Composition of the Emergency Task Force (ETF) for preparedness
Composition of the Emergency Task Force (ETF) for preparedness
Composition of the Emergency Task Force (ETF) for preparedness
Human medicines European public assessment report (EPAR): Osvyrti, denosumab, Date of authorisation: 26/05/2025, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Aybintio, bevacizumab, Date of authorisation: 19/08/2020, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Zemcelpro, allogeneic umbilical cord-derived CD34- cells, non-expanded,dorocubicel, Date of authorisation: 25/08/2025, Revision: 1, Status: Authorised
HMA-EMA joint Network Data Steering Group meeting - 6 November 2025
Funding
List of centrally authorised products with safety-related changes to the product information
EMA roundtable with stakeholders on the 20th anniversary of the SME Regulation, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 17 October 2025, 09:30 (CEST) to 17 October 2025, 14:30 (CEST)
Report - EMA roundtable with stakeholders on the 20th anniversary of the SME regulation
Plasma master file certificates